CClinicalTrials.gg
Status unknownNCT03141502SSDRCTUpdated May 5, 2017

The New Skin Stretching Device for Treatment of Limb Tension Wounds

A Phase 4 interventional study of Skin stretching device (SSD) and Skin grafting in Trauma, Fractures, Open and Wounds and Injuries, sponsored by The First Affiliated Hospital of Dalian Medical University. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-05.

Sponsored by The First Affiliated Hospital of Dalian Medical University · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A randomized controlled trial is performed to evaluate the effectiveness and safety of the Skin Stretching Device (SSD) on limb tension incision closure by comparing whether the differences in wounds area, wounds closure time and scar assessment between the SSD and the skin grafting are statistically significant.

Read the detailed description

Design:

This study is a multicenter and randomized control study with the participation of 15 major national or regional central hospitals. And the whole sample size is set to be 100 patients.

Patients who have been screened by inclusion and exclusion criteria will be randomly (non-transparent envelope) assigned to Skin Stretching Group (SS Group) or Skin Grafting Group (SG Group). Patients of both group will undergo surgical debridement for the same principle, while the Skin Stretching Device is used for the patients of SS Group for incision closure and the Skin Grafting is used for the patients of SG group for incision closure.

Outcome evaluation:

Wound and scar evaluation during surgery, three and six months after surgery will include the following parameters:

  • surface area;
  • Vancouver scar scale (VSS)
  • vascularization and pigmentation;
  • dermal architecture. After 3 and 6 months patients will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the SSD will undergo one extra biopsy of the formerly stretched skin.

Safety evaluation:

During the trial, adverse events are observed and evaluated. Adverse reactions to clinical manifestations are followed and recorded till the symptoms disappear. The subject with serious adverse events shall withdraw from the study and be treated accordingly.

02

Conditions studied

  • Trauma
  • Fractures, Open
  • Wounds and Injuries
  • Skin Expander

Keywords

  • tension wound
  • skin stretching device
  • skin grafting
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age≥18 years old
  2. Tension incision that cannot be directly closed due to limb trauma or surgical debridement
  3. Incision that cannot be directly closed after the incision decompression for fascia compartment syndrome and ischemia and reperfusion injury
  4. Both sides of the incision skin suitable for skin stretching

Exclusion criteria

Exclusion criteria:

  1. Age \<18 years old
  2. Skin disease
  3. Keloid history
  4. Local or systemic use of hormones
  5. Systemic diseases: for example, diabetes, immunodeficiency disease, vascular disease and etc.
  6. Other poor general state to result in inability for trial;
  7. Mental illness.
04

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Skin Stretching Device (SSD)

    the wound is primarily closed by aid of the SSD after necessary surgical debridement.

    Device: Skin stretching device (SSD)

  • Active comparator
    Skin Grafting (SG)

    the wound is primarily closed by the technique of skin grafting after necessary surgical debridement.

    Procedure: Skin grafting

Interventions

  • DeviceSkin stretching device (SSD)

    By making use of skin viscoelasticity, the special metal crochet of SSD would be embedded in both sides skin of the wound. Multiple cycles of stretching and relaxing wound lead to extended skin, changing the high tension incision into a low tension incision and facilitating the direct suture.

  • ProcedureSkin grafting

    the standard technique of skin grafting after wound preparation.

05

What researchers measure

Primary outcomes

  1. the change of surface area of the scar

    it is performed by tracing the area of the scar directly onto non-stretchable transparent sterile sheets. then digitized and analyzed by software.

    Time frame: change from surgery at 6 months

Secondary outcomes

  1. Operation time

    refers to the time required for the application of skin stretching device or skin grafting

    Time frame: during surgery

  2. Wound site and wound healing time

    record the site of the operation, and the time from the beginning of surgery to the complete healing of the wound.

    Time frame: from surgery to 6 months

  3. Vancouver scar scale (VSS)

    evaluate the scar scale by VSS

    Time frame: 3 and 6 months after surgery

  4. scar vascularization index

    use photometric analyzer to measure its erythema index, assessing its angiogenesis and vascularization

    Time frame: 3 and 6 months after surgery

  5. scar pigmentation index

    use photometric analyzer to measure its melanin index, assessing its pigmentation

    Time frame: 3 and 6 months after surgery

  6. collagen fibers arrangement under electron microscopy

    use the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the collagen fibers arrangement by Electron microscopy

    Time frame: surgery and 6 months after surgery

  7. dermal matrix arrangement under electron microscopy

    use the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the dermal matrix arrangement by Electron microscopy

    Time frame: surgery and 6 months after surgery

06

Study locations

1 site
  • the First Affiliated Hospital of Dalian Medical University
    Dalian, Liaoning 116011, China
    • Nuo Li · Contact · dyyykyb@163.com · 86-0411-83635963
    • Yinan Wang · Contact · dyfyjwb@163.com · 86-0411-83635963
    • Ming Lu, MD · Sub investigator
    • Deqiang Zhang, MD · Sub investigator
    • Chongyang Fu, MD · Sub investigator
    • Junwei Junwei, MD · Sub investigator
07

References and documents

Publications

  • Verhaegen PD, Bloemen MC, van der Wal MB, Vloemans AF, Tempelman FR, Beerthuizen GI, van Zuijlen PP. Skin stretching for primary closure of acute burn wounds. Burns. 2014 Dec;40(8):1727-37. doi: 10.1016/j.burns.2014.03.014. Epub 2014 Apr 16. PubMed 24746282 ↗
  • Verhaegen PDHM, van Trier AJM, Jongen SJM, Vlig M, Nieuwenhuis MK, Middelkoop E, van Zuijlen PPM. Efficacy of skin stretching for burn scar excision: a multicenter randomized controlled trial. Plast Reconstr Surg. 2011 May;127(5):1958-1966. doi: 10.1097/PRS.0b013e31820cf4be. PubMed 21228739 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03141502
Lead sponsor
The First Affiliated Hospital of Dalian Medical University
Responsible party
Sponsor
First posted
May 5, 2017
Start date
May 11, 2017 (estimated)
Primary completion
Aug 31, 2018 (estimated)
Completion
Oct 31, 2018 (estimated)
Last update
May 5, 2017

Study contacts

Junwei Zong, MD
Contact
aweizone@163.com
86041183635963 ext. 3131
Nuo Li
Contact
dyyykyb@163.com
86041183635963 ext. 3015
Xin Tang
principal investigator · The First Affiliated Hospital of Dalian Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion